Insulet
PODD
#1018
Rank
A$29.87 B
Marketcap
$425.89
Share price
3.90%
Change (1 day)
33.98%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): A$0.49 Billion

According to Insulet's latest financial reports the company's current earnings are A$1.98 Billion. In 2023 the company made an earning of A$0.40 Billion, an increase over its 2022 earnings that were of A$68.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.49 B24.56%
2023 A$0.40 B481.9%
2022 A$68.85 M-45.24%
2021 A$0.12 B43.35%
2020 A$87.71 M18.51%
2019 A$74.01 M41.16%
2018 A$52.43 M-711.95%
2017 -A$8.57 Million-56.85%
2016 -A$19.86 Million-79.31%
2015 -A$96 Million63.85%
2014 -A$58.59 Million31.04%
2013 -A$44.72 Million-21.96%
2012 -A$57.3 Million
2010 -A$54.65 Million-42.38%
2009 -A$94.84 Million-33.56%
2008 -A$0.15 Billion65.93%
2007 -A$86.03 Million209.75%
2006 -A$27.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$6.16 Million-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.2 Billion-136.81%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.21 B 126.11%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.38 B 5,351.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.82 B 1,908.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$9.45 B 1,654.59%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$16.21 B 2,908.45%๐Ÿ‡บ๐Ÿ‡ธ USA